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Abstract: The removal efficiency is used in literature as key indicator of the fate of pharmaceuticals in 
wastewater treatment plants. In this study, we used the recently developed Activated Sludge Modelling 
framework for Xenobiotics (ASM-X) to identify and evaluate the mechanisms affecting the removal 
efficiency in biological treatment systems. Model predictions for sulfamethoxazole, ciprofloxacin and 
tetracycline were generalized with published data derived from a critical literature selection. The 
biological removal efficiency was significantly underestimated when assessed based only on parent 
chemical fractions, showing the significance of retransformation processes. We also demonstrated that 
a dynamic evaluation of the removal of pharmaceuticals could lead to a more detailed assessment of 
the potential environmental risk. 
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Introduction 
Biological wastewater treatment plants (WWTPs) have a crucial role in the mitigation 
of the environmental risk posed by the release of pharmaceuticals. A number of 
factors are known to influence the removal of pharmaceuticals. Among others, we 
note: (i) dynamics in the influent loads (related to e.g., administration patterns) and in 
the operation of WWTPs; (ii) the sludge retention time (SRT) of biological systems, 
possibly inducing an increase in the metabolic capabilities of biomass; and (iii) the 
occurrence of retransformation processes (e.g., deconjugation of human metabolites) 
in upstream sewers and in bioreactors. With regard to the latter, the concentration of 
human metabolites that can retransform to the parent form was found to be greater 
than the parent concentration itself (Göbel et al., 2005). The assessment of the actual 
removal processes can therefore be misleading, if the removal efficiency is estimated 
by using data only on parent chemicals—as usually occurring in literature.  
An Activated Sludge Modelling framework for Xenobiotics (ASM-X) was recently 
tested in the fate prediction of pharmaceuticals in an activated sludge WWTP (Plósz 
et al., 2010, 2012). Based on these predictions, we generalized the removal of three 
pharmaceuticals (sulfamethoxazole, ciprofloxacin, tetracycline) with worldwide 
literature data. The objectives of this generalization were: (i) to validate ASM-X 
predictions with literature data; and (ii) to assess the effects of the mentioned 
influencing factors on the full-scale removal of the substances. Additionally, we 
investigated the effect of effluent dynamics on the risk prediction in recipient bodies. 
Material and Methods 
Based on the ASM-X predictions presented by Plósz et al. (2010), average removal 
efficiencies [%] of sulfamethoxazole, ciprofloxacin and tetracycline in Bekkelaget 
WWTP (Oslo, Norway) were estimated and plotted as a function of the influent load 
of the substances [mg h
-1
 1000PE
-1
]. Distinct removal efficiencies were calculated 
considering i) only the parent compound fraction and ii) both the parent and the 
retransformable fractions. International data on the removal of pharmaceuticals, 
resulting from WWTP measuring campaigns, were used for the generalization. A 
number of criteria were defined for the literature selection, e.g. the use of suitable 
wastewater sampling techniques. An environmental risk assessment of the chemicals 
was performed by calculating predicted environmental concentrations (PECs) from 
the effluent concentrations reported by Plósz et al. (2010). 
Results and Conclusions 
For a meaningful comparison of removal efficiencies at the influent loadings reported 
in literature, scenario simulations with ASM-X were considered. Model predictions 
with 5-fold increased influent loading were found to reproduce the efficiencies 
reported by Göbel et al. (2005, 2007) (Fig. 1). A significant underestimation error 
occurred when only the parent fraction was considered, as compared to when N4-
acetyl-sulfamethoxazole (a major metabolite) was accounted. The comparable 
elimination performances of the WWTPs assessed could be associated to similar 
operational conditions in the WWTPs and impacts of in-sewer retransformation on 
influent characteristics. Removal efficiencies reported by Radjenovic et al. (2009)—
based on only parent removal—were higher than predicted ones both for activated 
sludge and membrane bioreactor, suggesting that in-sewer retransformation could 
have overcome the effect of SRT (> 60 d) increase in the latter bioreactor type. 
Furthermore, the comparably higher efficiencies reported by Yang et al. (2011) were 
possibly related to the employment of membrane filtration in the monitored WWTP. 
 
Figure 1 Generalization of predicted removal of sulfamethoxazole (SMX) through ASM-X with 
literature data. ASM-X predictions of removal efficiency accounted for only parent SMX (grey 
diamonds) and for parent and retransformable fractions of SMX (black circles). Error bars refer to 
standard deviations in influent loadings and removal efficiencies. Removal efficiencies from Göbel et 
al. (2005, 2007) were calculated based as average of published data on SMX and N4-acetyl-
sulfamethoxazole (N4-Ac SMX). 
 
Results from the preliminary risk assessment showed the potential risk associated to 
sulfamethoxazole (Fig. 2a) and tetracycline (Fig. 2b) in the recipient water bodies of 
Bekkelaget. A low additional risk potential was related to the retransformable fraction 
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of sulfamethoxazole, as a result of its comparably high retransformation rate in 
activated sludge (Plósz et al., 2010). On the other hand, the retransformable fraction 
of tetracycline was found to substantially impact the PEC value of the substance (up 
to 130% increase as compared to parent-based PEC).  
 
Figure 2 PEC values of sulfamethoxazole (SMX-a) and tetracycline (TCY-b), calculated from ASM-X 
predictions. We distinguished between PECs accounting for only parent (grey dashed line) and parent 
plus retransformable (black line). For the purpose of risk assessment, PECs were compared with acute 
and chronic predicted non-effect concentrations (PNEC). Quasi MECs (measured environmental 
concentrations) identify effluent measured environmental concentrations divided by a dilution factor.  
 
These results suggest that a comprehensive evaluation of the removal of 
pharmaceuticals in biological WWTPs is required for a more detailed assessment of 
the risk derived by their environmental release.   
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